# mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

> **NCT01676779** · PHASE2 · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 88 (estimated)

## Conditions studied

- Malignant Melanoma Stage III
- Malignant Melanoma Stage IV

## Interventions

- **BIOLOGICAL:** Dendritic cell therapy

## Key facts

- **NCT ID:** NCT01676779
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-09
- **Final completion:** 2016-09
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2017-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676779, "mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01676779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*